D. Hanahan and R. Weinberg, Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-674, 2011.
DOI : 10.1016/j.cell.2011.02.013

F. Klemm and J. Joyce, Microenvironmental regulation of therapeutic response in cancer, Trends in Cell Biology, vol.25, issue.4, pp.198-213, 2015.
DOI : 10.1016/j.tcb.2014.11.006

D. Quail and J. Joyce, Microenvironmental regulation of tumor progression and metastasis, Nature Medicine, vol.87, issue.11, pp.1423-1437, 2013.
DOI : 10.1016/j.ccr.2013.02.013

D. Wang and R. Dubois, Eicosanoids and cancer, Nature Reviews Cancer, vol.133, issue.3, pp.181-193, 2010.
DOI : 10.1038/nrc2809

S. Barondes, V. Castronovo, D. Cooper, R. Cummings, K. Drickamer et al., Galectins: A family of animal ??-galactoside-binding lectins, Cell, vol.76, issue.4, pp.597-598, 1994.
DOI : 10.1016/0092-8674(94)90498-7

F. Liu and G. Rabinovich, Galectins as modulators of tumour progression, Nature Reviews Cancer, vol.19, issue.1, pp.29-41, 2005.
DOI : 10.1038/nrc1275

G. Vasta, Roles of galectins in infection, Nature Reviews Microbiology, vol.6, issue.6, pp.424-438, 2009.
DOI : 10.1038/nrmicro2146

W. Wang, H. Guo, J. Geng, X. Zheng, H. Wei et al., Tumor-released Galectin-3, a Soluble Inhibitory Ligand of Human NKp30, Plays an Important Role in Tumor Escape from NK Cell Attack, Journal of Biological Chemistry, vol.289, issue.48, pp.33311-33319, 2014.
DOI : 10.1074/jbc.M114.603464

K. Stannard, P. Collins, K. Ito, E. Sullivan, S. Scott et al., Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model, Cancer Letters, vol.299, issue.2, pp.95-110, 2010.
DOI : 10.1016/j.canlet.2010.08.005

R. Yang, G. Rabinovich, and F. Liu, Galectins: structure, function and therapeutic potential, Expert Reviews in Molecular Medicine, vol.121, p.17, 2008.
DOI : 10.2353/ajpath.2008.070348

H. Inohara and A. Raz, Effects of natural complex carbohydrate (citrus pectin) on murine melanoma cell properties related to galectin-3 functions, Glycoconjugate Journal, vol.46, issue.6, pp.527-532, 1994.
DOI : 10.1007/BF00731303

K. Pienta, H. Naik, A. Akhtar, K. Yamazaki, T. Replogle et al., Inhibition of Spontaneous Metastasis in a Rat Prostate Cancer Model by Oral Administration of Modified Citrus Pectin, JNCI Journal of the National Cancer Institute, vol.87, issue.5, pp.348-353, 1995.
DOI : 10.1093/jnci/87.5.348

P. Nangia-makker, V. Hogan, Y. Honjo, S. Baccarini, L. Tait et al., Inhibition of Human Cancer Cell Growth and Metastasis in Nude Mice by Oral Intake of Modified Citrus Pectin, JNCI Journal of the National Cancer Institute, vol.94, issue.24, pp.1854-1862, 2002.
DOI : 10.1093/jnci/94.24.1854

R. Dings, M. Miller, I. Nesmelova, L. Astorgues-xerri, N. Kumar et al., Antitumor Agent Calixarene 0118 Targets Human Galectin-1 as an Allosteric Inhibitor of Carbohydrate Binding, Journal of Medicinal Chemistry, vol.55, issue.11, pp.5121-5129, 2012.
DOI : 10.1021/jm300014q

C. Villeneuve, L. Baricault, L. Canelle, N. Barboule, C. Racca et al., Mitochondrial proteomic approach reveals galectin-7 as a novel BCL-2 binding protein in human cells, Molecular Biology of the Cell, vol.22, issue.7, pp.999-1013, 2011.
DOI : 10.1091/mbc.E10-06-0534

A. Paz, R. Haklai, G. Elad-sfadia, E. Ballan, and Y. Kloog, Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation, Oncogene, vol.20, issue.51, pp.7486-7493, 2001.
DOI : 10.1038/sj.onc.1204950

S. Akahani, P. Nangia-makker, H. Inohara, H. Kim, and A. Raz, Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family, Cancer Res, vol.57, pp.5272-5276, 1997.

T. Shimura, Y. Takenaka, T. Fukumori, S. Tsutsumi, K. Okada et al., Implication of Galectin-3 in Wnt Signaling, Cancer Research, vol.65, issue.9, pp.3535-3537, 2005.
DOI : 10.1158/0008-5472.CAN-05-0104

D. Cooper, Galectinomics: finding themes in complexity, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1572, issue.2-3, pp.209-231, 2002.
DOI : 10.1016/S0304-4165(02)00310-0

N. Fink, Soluble ?-galactoside-binding lectins [Article in Spanish], Acta Physiol Pharmacol Ther Latinoam, vol.46, pp.1-10, 1996.

S. Barondes, D. Cooper, M. Gitt, H. Leffler, and . Galectins, Structure and function of a large family of animal lectins, J Biol Chem, vol.269, pp.20807-20810, 1994.

V. Giudicelli, D. Lutomski, M. Levi-strauss, D. Bladier, R. Joubert-caron et al., Is human galectin-1 activity modulated by monomer/dimer equilibrium?, Glycobiology, vol.7, issue.3, p.viii?x, 1997.
DOI : 10.1093/glycob/7.3.323-a

G. Levi and V. Teichberg, Isolation and physicochemical characterization of electrolectin, a ?-D-galactoside binding lectin from the electric organ of Electrophorus electricus, J Biol Chem, vol.256, pp.5735-5740, 1981.

F. Brewer and C. , Binding and cross-linking properties of galectins, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1572, issue.2-3, pp.255-262, 2002.
DOI : 10.1016/S0304-4165(02)00312-4

G. Rabinovich, M. Toscano, S. Jackson, and G. Vasta, Functions of cell surface galectin-glycoprotein lattices, Current Opinion in Structural Biology, vol.17, issue.5, pp.513-520, 2007.
DOI : 10.1016/j.sbi.2007.09.002

O. Garner and L. Baum, Galectin???glycan lattices regulate cell-surface glycoprotein organization and signalling: Table 1, Biochemical Society Transactions, vol.36, issue.6, pp.1472-1477, 2008.
DOI : 10.1042/BST0361472

T. Hebert, S. Moffett, J. Morello, T. Loisel, D. Bichet et al., A Peptide Derived from a ??2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation, Journal of Biological Chemistry, vol.271, issue.27, pp.16384-16392, 1996.
DOI : 10.1074/jbc.271.27.16384

S. George, S. Lee, G. Varghese, P. Zeman, P. Seeman et al., A Transmembrane Domain-derived Peptide Inhibits D1 Dopamine Receptor Function without Affecting Receptor Oligomerization, Journal of Biological Chemistry, vol.273, issue.46, pp.30244-30248, 1998.
DOI : 10.1074/jbc.273.46.30244

E. Ermakova, M. Miller, I. Nesmelova, L. Lopez-merino, M. Berbis et al., Lactose binding to human galectin-7 (p53-induced gene 1) induces long-range effects through the protein resulting in increased dimer stability and evidence for positive cooperativity, Glycobiology, vol.23, issue.5, pp.508-523, 2013.
DOI : 10.1093/glycob/cwt005

R. Jahnel, M. Dreger, C. Gillen, O. Bender, J. Kurreck et al., Biochemical characterization of the vanilloid receptor 1 expressed in a dorsal root ganglia derived cell line, European Journal of Biochemistry, vol.274, issue.21, pp.5489-5496, 2001.
DOI : 10.1046/j.1432-1033.2001.02500.x

J. Klodmann, D. Lewejohann, H. Braun, . Low, and P. Blue-native, Low-SDS Blue native PAGE, PROTEOMICS, vol.17, issue.9, pp.1834-1839, 2011.
DOI : 10.1002/pmic.201000638

C. Lin, Y. Huang, and J. Richter, Transient CPEB dimerization and translational control, RNA, vol.18, issue.5, pp.1050-1061, 2012.
DOI : 10.1261/rna.031682.111

T. Hoang, M. Smith, and M. Jelokhani-niaraki, Expression, Folding, and Proton Transport Activity of Human Uncoupling Protein-1 (UCP1) in Lipid Membranes: EVIDENCE FOR ASSOCIATED FUNCTIONAL FORMS, Journal of Biological Chemistry, vol.288, issue.51, pp.36244-36258, 2013.
DOI : 10.1074/jbc.M113.509935

A. Giudici, M. Molina, J. Ayala, E. Montoya, M. Renart et al., Detergent-labile, supramolecular assemblies of KcsA: Relative abundance and interactions involved, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1828, issue.2, pp.193-200, 2013.
DOI : 10.1016/j.bbamem.2012.09.020

K. Ito, K. Stannard, E. Gabutero, A. Clark, S. Neo et al., Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment, Cancer and Metastasis Reviews, vol.286, issue.24, pp.763-778, 2012.
DOI : 10.1007/s10555-012-9388-2

G. Radosavljevic, V. Volarevic, I. Jovanovic, M. Milovanovic, N. Pejnovic et al., The roles of Galectin-3 in autoimmunity and tumor progression, Immunologic Research, vol.176, issue.3, pp.100-110, 2012.
DOI : 10.1007/s12026-012-8286-6

M. Labrie, M. Vladoiu, A. Grosset, L. Gaboury, Y. St-pierre et al., Expression and functions of galectin-7 in ovarian cancer, Oncotarget, vol.5, issue.17, pp.7705-772112670, 2009.
DOI : 10.18632/oncotarget.2299

URL : https://hal.archives-ouvertes.fr/pasteur-01135767

M. Tribulatti, J. Mucci, V. Cattaneo, F. Aguero, T. Gilmartin et al., Galectin-8 Induces Apoptosis in the CD4highCD8high Thymocyte Subpopulation, Glycobiology, vol.17, issue.12, pp.1404-1412, 2007.
DOI : 10.1093/glycob/cwm104

Y. Fukata, A. Itoh, Y. Nonaka, T. Ogawa, T. Nakamura et al., Direct cytocidal effect of galectin-9 localized on collagen matrices on human immune cell lines, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1840, issue.6, pp.1892-1901, 2014.
DOI : 10.1016/j.bbagen.2014.01.019

N. Perillo, K. Pace, J. Seilhamer, and L. Baum, Apoptosis of T cells mediated by galectin-1, Nature, vol.119, issue.6558, pp.736-739, 1995.
DOI : 10.1038/378736a0

B. Stillman, D. Hsu, M. Pang, C. Brewer, P. Johnson et al., Galectin-3 and Galectin-1 Bind Distinct Cell Surface Glycoprotein Receptors to Induce T Cell Death, The Journal of Immunology, vol.176, issue.2, pp.778-789, 2006.
DOI : 10.4049/jimmunol.176.2.778

J. Xue, X. Gao, C. Fu, Z. Cong, H. Jiang et al., -glycans on CD45, FEBS Letters, vol.52, issue.24, pp.3986-3994, 2013.
DOI : 10.1016/j.febslet.2013.10.034

URL : https://hal.archives-ouvertes.fr/hal-00907664

K. Henrick, S. Bawumia, E. Barboni, B. Mehul, and R. Hughes, Evidence for subsites in the galectins involved in sugar binding at the nonreducing end of the central galactose of oligosaccharide ligands: Sequence analysis, homology modeling and mutagenesis studies of hamster galectin-3, Glycobiology, vol.8, issue.1, pp.45-57, 1998.
DOI : 10.1093/glycob/8.1.45

D. Oliver, R. Cabelli, K. Dolan, and G. Jarosik, Azide-resistant mutants of Escherichia coli alter the SecA protein, an azide-sensitive component of the protein export machinery., Proceedings of the National Academy of Sciences, vol.87, issue.21, pp.8227-8231, 1990.
DOI : 10.1073/pnas.87.21.8227

B. Kubak and W. Yotis, Staphylococcus aureus adenosine triphosphatase: inhibitor sensitivity and release from membrane, J Bacteriol, vol.146, pp.385-390, 1981.

C. Boscher, J. Dennis, and I. Nabi, Glycosylation, galectins and cellular signaling, Current Opinion in Cell Biology, vol.23, issue.4, pp.383-392, 2011.
DOI : 10.1016/j.ceb.2011.05.001

T. Yamaguchi, K. Hiromasa, R. Kabashima-kubo, M. Yoshioka, and M. Nakamura, -urocanic acid and ultraviolet B irradiation, down-modulates cytokine production by T lymphocytes, Experimental Dermatology, vol.22, issue.12, pp.840-842, 2013.
DOI : 10.1111/exd.12268

URL : https://hal.archives-ouvertes.fr/hal-00857429

N. Doan, M. Letourneau, D. Vaudry, N. Doucet, B. Folch et al., Design and characterization of novel cell-penetrating peptides from pituitary adenylate cyclase-activating polypeptide, Journal of Controlled Release, vol.163, issue.2, pp.256-265, 2012.
DOI : 10.1016/j.jconrel.2012.08.021

URL : https://hal.archives-ouvertes.fr/pasteur-00818553

A. Brkovic, A. Hattenberger, E. Kostenis, T. Klabunde, S. Flohr et al., Functional and Binding Characterizations of Urotensin II-Related Peptides in Human and Rat Urotensin II-Receptor Assay, Journal of Pharmacology and Experimental Therapeutics, vol.306, issue.3, pp.1200-1209, 2003.
DOI : 10.1124/jpet.103.052415